Portfolio company
Kano
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This biotechnology company develops and manufactures circular single-stranded DNA templates to improve the delivery of gene therapies for medical research and pharmaceutical partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kano Therapeutics
This company manufactures circular single-stranded DNA templates for biotechnology and pharmaceutical partners to enable gene insertions in cell and gene therapy.
Artis BioSolutions
The company produces synthetic DNA and manufacturing services for biotechnology and pharmaceutical firms developing genetic medicines and advanced therapies.
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
Anjarium BioSciences
This company develops non-viral gene therapies and synthetic DNA vectors for patients with genetic diseases and life sciences researchers.
Bitrobius Genetics
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
Kamau Therapeutics
This company develops clinical-stage gene correction therapies using targeted DNA integration to treat patients with sickle cell disease and other genetic conditions.
Aera Therapeutics
This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.
